Interestingly, LIPC gene mutation is the second most common cause of familial hypocholesterolemia, after only angiopoietin-like 3 (ANGPTL3) [38], suggesting that LIPC is a promising target for the diagnosis of familial hypocholesterolemia. The gene discussed is LIPC; the disease is Hypocholesterolemia.